Oriola

Finnish medical industry business

OKDAV Nasdaq Helsinki LEI 549300UWB1AIR85BM957
Follow Oriola Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2025 EUR · IFRS
Revenue, last year €1.9B +13.5% vs prior year
Net income −€27.2M −35.3% vs prior year
EPS, diluted −€0.15 −36.4% vs prior year
Operating cash flow €60M +55% vs prior year
Revenue by fiscal year
€1.8B
€1.9B
€1.5B
€1.5B
€1.7B
€1.9B
FY20 FY21 FY22 FY23 FY24 FY25

Source: ESEF annual reports · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−€500M€0€500M€1B€1.5B€2BFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25€1.9B−€27.2M
FY24€1.7B−€20.1M
FY23€1.5B−€20.7M
FY22€1.5B−€2.4M
FY21€1.9B€11.3M
FY20€1.8B€11.3M
FY19€1.7B€8M
MarginsShare of revenue
  • Operating margin
  • Net margin
−2%−1%0%1%2%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY250.1%−1.4%
FY240.8%−1.2%
FY23−0.4%−1.4%
FY220.5%−0.2%
FY211.1%0.6%
FY201.1%0.6%
FY190.9%0.5%
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
€0€5M€10M€15M€20MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearDividendsBuybacks
FY25€12.7M€100K
FY24€12.7M€100K
FY23€10.9M€100K
FY22€7.3M€100K
FY21€5.4M€100K
FY20€16.3M€100K
FY19€16.3M€100K
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Oriola
  • Healthcare median
−100%−75%−50%−25%0%25%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOriolaHealthcare median
FY25−1.4%−30.6%
FY24−1.2%−47%
FY23−1.4%−58%
FY22−0.2%−80.4%
FY210.6%−71.9%
FY200.6%−62.2%
FY190.5%−46.3%